GLP-1 is an abbreviation for Glucagon-Like Peptide-1 receptor agonist, which is a class of medications commonly used to treat diabetes and to assist with weight loss in patients with or without diabetes
The biggest obstacle for the medications is the cost, said Pouya Shafipour, MD, a family and obesity medicine physician at Providence Saint Johns Health Center in California
Importantly, none of the trials in T1D reported an increase in diabetic ketoacidosis (DKA) a key concern that has limited the use of SGLT2 inhibitors in T1D
Keep in mind that medication works differently for everybody speak to your healthcare provider if you have questions about how it works for you
This may affect medications with a narrow therapeutic index, so monitoring may be required
Patients deserve care that is individualized, Hernandez said